IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients

Aharon Kessel(Technion – Israel Institute of Technology), Elias Toubi(Bnai Zion Medical Center), Gleb Slobodin(Bnai Zion Medical Center), Edmond Sabo(Carmel Medical Center), Itzhak Rosner(Bnai Zion Medical Center), Regina Peri(Technion – Israel Institute of Technology), Yehuda Shoenfeld(Weizmann Institute of Science), Tharwat Haj(Technion – Israel Institute of Technology), Ayelet Snir(Technion – Israel Institute of Technology)
Journal of Clinical Immunology
October 4, 2010
10.1007/s10875-010-9469-3
Cited by 45

Related Papers

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.4k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Allergy|2014|1.2k
Hydroxychloroquine: From Malaria to Autoimmunity
|Clinical Reviews in Allergy & Immunology|2011|612
The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Dermatology Review|2015|428